Agios Pharmaceuticals
AGIO
#5107
Rank
C$2.46 B
Marketcap
C$41.22
Share price
-3.10%
Change (1 day)
31.38%
Change (1 year)

Market capitalization of Agios Pharmaceuticals (AGIO)

Market cap: C$2.46 Billion

As of November 2026 Agios Pharmaceuticals has a market cap of C$2.46 Billion. This makes Agios Pharmaceuticals the world's 5107th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Agios Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026C$2.46 B10.17%
2025C$2.23 B-18.14%
2024C$2.73 B65.57%
2023C$1.65 B-21.14%
2022C$2.09 B-7.98%
2021C$2.27 B-40.55%
2020C$3.82 B-10.3%
2019C$4.26 B16.65%
2018C$3.65 B4.35%
2017C$3.50 B48.73%
2016C$2.35 B-30.6%
2015C$3.39 B-29.62%
2014C$4.82 B506.39%
2013C$0.79 B

End of Day market cap according to different sources

On Nov 19th, 2026 the market cap of Agios Pharmaceuticals was reported to be:

C$2.46 Billion
by Nasdaq info icon info icon
C$2.46 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
C$224.95 B 9,025.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$1.724 T 69,866.02%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$137.36 B 5,472.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
C$3.65 B 48.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$23.02 B 833.84%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$17.04 B 591.62%๐Ÿ‡บ๐Ÿ‡ธ USA